NASDAQ · AIFF

Firefly Neuroscience, Inc.

$1.11 +$0.01 (+0.91%) 1D After hours

Key Metrics

$17.32M
Market cap
P/E · TTM
$1.58M
Revenue · TTM
−$8.96M
Net income
EPS · TTM $-0.74
Dividend yield
Free cash flow
Beta · 1Y 1.70
EBITDA · TTM −$8.75M
Gross margin 54.7%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 28
    Money has been moving out of its sector (Technology).

    Technology has run -4.1 points vs SPY over four weeks, ranking 8→2→11→7 of 11 sectors — this stock trades inside that current.

    RECEIPT: ROTATION MAP, LIVE ↗
  • Jul 23
    From its Mar 26 high, the share price fell 64%.

    Peak close $3.02 on Mar 26; trough close $1.10 on Jul 23. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -64%
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Mar 26
    The stock moved +79.8% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 26
  • Mar 4
    The stock moved +126.3% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 4

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$17.32M
Enterprise value
Shares outstanding15.6M
52-wk range$0.62 – $3.63
Avg volume · 20D3.0M
Net cash
Book value / share$0.70
IndustryServices-Prepackaged Software
ExchangeNASDAQ
About Firefly Neuroscience, Inc.
IPO dateAug 13, 2024
Employees17

Firefly Neuroscience Inc is an artificial intelligence company advancing precision neuroscience, applying AI and large-scale electrophysiological data to give clinicians a more complete, objective picture of how an individual patient's brain is functioning.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S10.94
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross 54.7%
Operating -565.1%
Net -565.4%
FCF
ROE / ROIC -222.0% · -168.5%

Financial Health

Current ratio1.82
Quick ratio1.78
Debt / equity
Debt / EBITDA
Net cash
Working capital$2.01M

Cash Flow · TTM

Operating CF −$7.63M
Capex
Free cash flow
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

4 / 9
Middling fundamentals · 4 of 9 signals passing

Altman Z-Score

-12.7
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings